Sernova Corp. (TSE:SVA – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as C$0.18 and last traded at C$0.19, with a volume of 1500 shares traded. The stock had previously closed at C$0.18.
Sernova Price Performance
The stock has a market capitalization of C$62.25 million, a P/E ratio of -1.79 and a beta of 1.35. The company has a debt-to-equity ratio of -4.40, a quick ratio of 18.11 and a current ratio of 0.32. The firm has a fifty day moving average price of C$0.20 and a two-hundred day moving average price of C$0.23.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Read More
- Five stocks we like better than Sernova
- 5 discounted opportunities for dividend growth investors
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Must-Own Stocks to Build Wealth This Decade
- Stock Average Calculator
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
